{"id":1738,"date":"2018-12-16T06:28:23","date_gmt":"2018-12-16T06:28:23","guid":{"rendered":"https:\/\/crigroup.com\/?post_type=case-study&p=1738"},"modified":"2022-03-30T08:40:13","modified_gmt":"2022-03-30T08:40:13","slug":"pharma-due-diligence","status":"publish","type":"case-study","link":"https:\/\/crigroup.com\/ar\/case-study\/pharma-due-diligence\/","title":{"rendered":"Major Pharma conducts due diligence investigation: lessons learned"},"content":{"rendered":"
UNETHICAL PRACTICES, CONFLICT OF INTEREST, BRIBERY, AND CORRUPTION DISCOVERED AMONG A RANGE OF EMPLOYEES <\/strong>AT MAJOR PHARMA COMPANY, EVEN THE CFO WAS ON THE TAKE –<\/em><\/p>\n A major pharmaceutical company engaged CRI Group to conduct an integrity due diligence and conflict of interest investigation. The focus of the action was to uncover unethical practices, including bribery and corruption, by senior employees. The client\u2019s corporate security department had received conflict of interest complaints that reportedly involved a range of employees, from sales personnel on up to the chief financial officer (CFO).<\/p>\n This ebook examines the following:<\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n Who is CRI<\/span><\/strong>\u00ae<\/span>\u00a0Group?<\/span><\/strong><\/p>\n Based in London, CRI\u00ae Group works with companies across the Americas, Europe, Africa, Middle East and Asia-Pacific as a one-stop international\u00a0<\/span>Risk Management<\/span><\/a>,\u00a0<\/span>Employee Background Screening<\/span><\/a>,\u00a0<\/span>Business Intelligence<\/span><\/a>,\u00a0<\/span>TPRM<\/span><\/a>,\u00a0<\/span>Due Diligence<\/span><\/a>,\u00a0<\/span>Compliance Solutions<\/span><\/a>\u00a0and other professional\u00a0<\/span>Investigative Research<\/span><\/a>\u00a0solutions provider. We have the largest proprietary network of background-screening analysts and investigators across the Middle East and Asia. Our global presence ensures that no matter how international your operations are we have the network needed to provide you with all you need, wherever you happen to be. CRI\u00ae Group also holds\u00a0<\/span>BS 102000:2013<\/span><\/strong>\u00a0and\u00a0<\/span>BS 7858:2012 Certifications<\/span><\/strong>, is an HRO certified provider and partner with Oracle.<\/span><\/p>\n In 2016, CRI\u00ae Group launched\u00a0<\/span>Anti-Bribery Anti-Corruption (ABAC\u00ae) Center of Excellence<\/span><\/a>\u00a0\u2013 an independent certification body that provides education and certification services for individuals and organisations on a wide range of disciplines and ISO standards, including\u00a0<\/span>ISO 31000:2018 Risk Management- Guidelines<\/span><\/a>;\u00a0<\/span>ISO 37000:2021 Governance of Organisations<\/span><\/a>;\u00a0<\/span>ISO 37002:2021 Whistleblowing Management System<\/span><\/a>;\u00a0<\/span>ISO 37301:2021 (formerly ISO 19600) Compliance Management system (CMS)<\/span><\/a>;\u00a0<\/span>Anti-Money Laundering (AML)<\/span><\/a>; and\u00a0<\/span>ISO 37001:2016 Anti-Bribery Management Systems ABMS<\/span><\/a>. ABAC\u00ae offers a complete suite of solutions designed to help organisations mitigate the internal and external risks associated with operating in multi-jurisdiction and multi-cultural environments while assisting in developing frameworks for strategic compliance programs.\u00a0<\/span>Contact ABAC\u00ae for more<\/span><\/a>\u00a0on ISO Certification and training.<\/span><\/p>\n <\/p>\n","protected":false},"featured_media":8506,"template":"","categories":[24,21,12,13,36],"tags":[33,35,70,132,133,134],"class_list":["post-1738","case-study","type-case-study","status-publish","has-post-thumbnail","hentry","category-all-regions","category-background-investigation","category-due-diligence","category-employee-background-check","category-pharmaceutical-healthcare","tag-bribery","tag-corruption","tag-due-diligence","tag-pharma","tag-risk-assessment","tag-unethical-practices"],"yoast_head":"\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\n\n\n\t\n\n
Download your FREE ebook here<\/a>!<\/h3>\n
<\/a><\/p>\n